MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Gross proceeds from issuance of ...
Gross proceeds from issuance of ...
Prepaid and other current assets
Others
Negative Cash Flow Breakdown
Net loss
Accounts payable and accrued exp...
Forgiveness of unrelated vendor ...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-1,407,259
-1,123,714
-8,168,927
-1,823,351
Forgiveness of unrelated vendor payables
11,515
-
0
0
Forgiveness of related party receivables
-
-
126,275
-
Depreciation
468
518
543
542
Change in fair value of deferred underwriting fee - paid in common stock
-
-
0
560,000
Change in the fair value of warrant liabilities
29,245
4,178
-94,335
-76,871
Loss on issuance of common stock in connection with the surrendar of warrants
-
-
0
-1,740,000
Fair value of common stock to be issued for contingent liability
-
-
7,360,000
-
Due from related party, current
-
-
0
0
Prepaid and other current assets
-495,501
707,953
-315,949
34,782
Accounts payable and accrued expenses
-102,128
-191,956
23,064
-2,014,999
Accrued interest, related parties
-18,845
-18,637
-19,051
-19,052
Due to related party
6,844
-14,999
31,533
7,500
Net cash used in operating activities
-969,999
-2,015,289
-386,847
-600,612
Loans to iris acquisition corp
-
-
0
0
Purchases of property and equipment
-
-
0
13,108
Net cash used in investing activities
-
-
0
-13,108
Proceeds from issuance of common stock, net
-
3,585,308
0
0
Payment of transaction costs
-
-
0
0
Gross proceeds from issuance of common stock in connection with the offering
3,585,308
-
-
-
Proceeds from issuance of short-term debt, related party
-
-
0
0
Gross proceeds from issuance of common stock in connection-Common Stock Warrants
217,500
-
-
-
Repayment of short-term debt, related party
-
-
0
0
Gross proceeds from issuance of common stock in connection-Existing Warrants
1,861,921
-
-
-
Net cash provided by financing activities
2,079,421
3,585,308
0
0
Net change in cash
1,109,422
1,570,019
-386,847
-613,720
Cash, beginning of the period
1,907,674
337,655
1,338,222
1,338,222
Cash, end of the period
3,017,096
1,907,674
337,655
724,502
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Gross proceeds from
issuance of common stock...
$3,585,308
Gross proceeds from
issuance of common stock...
$1,861,921
Gross proceeds from
issuance of common stock...
$217,500
Net cash provided by
financing activities
$2,079,421
(-81.15%↓ Y/Y)
Canceled cashflow
$3,585,308
Net change in cash
$1,109,422
(-13.46%↓ Y/Y)
Canceled cashflow
$969,999
something is missing
-$3,585,308
Prepaid and other
current assets
-$495,501
(-1040.60%↓ Y/Y)
Change in the fair value
of warrant...
$29,245
(-74.98%↓ Y/Y)
Accrued interest,
related parties
-$18,845
(89.40%↑ Y/Y)
Due to related party
$6,844
(106.74%↑ Y/Y)
Depreciation
$468
(-37.01%↓ Y/Y)
Net cash used in
operating activities
-$969,999
(89.19%↑ Y/Y)
Canceled cashflow
$550,903
Net loss
-$1,407,259
(-556.86%↓ Y/Y)
Accounts payable and
accrued expenses
-$102,128
(95.00%↑ Y/Y)
Forgiveness of unrelated
vendor payables
$11,515
(-99.46%↓ Y/Y)
Buy us a coffee
Liminatus Pharma, Inc. (LIMNW)
Liminatus Pharma, Inc. (LIMNW)